强生股票:买入 IMAAVY 标签扩展优先 CAPLYTA 销售推动 (NYSE:JNJ)
· seekingalpha.com
强生公司 (JNJ) 维持买入评级,因 2026 年第二季度销售额跃升且指引上调。
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you ...